FDA NDC Directory · JSON-LD · Markdown
NDC 51991-992 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION
| Labeler / Manufacturer | Breckenridge Pharmaceutical, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA217640 |
| Dosage form / route | TABLET, FOR SUSPENSION · ORAL |
| Active ingredients | EVEROLIMUS (5 mg/1) |
| Marketing started | 20250128 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).